Rigel Pharmaceuticals Inc Financial Flexibility Index
Rigel Pharmaceuticals Inc financial flexibility index. Rigel Pharmaceuticals Inc (RIGL) has a Financial Flexibility Index of 0.32x as of June 2026. Free cash flow of $30.65 Million (operating CF $30.65 Million minus capex $0.00) represents 0% of total liabilities ($95.42 Million). See Rigel Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Rigel Pharmaceuticals Inc (1999–2025)
Financial flexibility index of Rigel Pharmaceuticals Inc from 1999 to 2025. Historical Financial Flexibility Index trend for Rigel Pharmaceuticals Inc across 27 annual periods. Check RIGL cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Rigel Pharmaceuticals Inc Financial Flexibility Index by Year (1999–2025)
Rigel Pharmaceuticals Inc financial flexibility index by year from 1999 to 2025. Year-by-year free cash flow to debt coverage for Rigel Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Rigel Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | $75.66 Million | $75.66 Million | $122.11 Million | ▲ +212.4% |
| 2024 | 0.20x | $31.87 Million | $31.47 Million | $160.69 Million | ▲ +212.5% |
| 2023 | 0.06x | $9.26 Million | $-5.74 Million | $145.87 Million | ▲ +112.8% |
| 2022 | -0.50x | $-73.31 Million | $-73.76 Million | $147.90 Million | ▼ -1143.6% |
| 2021 | 0.05x | $6.50 Million | $5.88 Million | $136.95 Million | ▲ +107.1% |
| 2020 | -0.67x | $-50.92 Million | $-52.19 Million | $76.35 Million | ▼ -56.1% |
| 2019 | -0.43x | $-40.05 Million | $-41.51 Million | $93.75 Million | ▲ +78.4% |
| 2018 | -1.97x | $-57.72 Million | $-58.83 Million | $29.23 Million | ▲ +52.9% |
| 2017 | -4.19x | $-77.39 Million | $-77.56 Million | $18.46 Million | ▼ -29.0% |
| 2016 | -3.25x | $-75.08 Million | $-75.89 Million | $23.11 Million | ▼ -473.6% |
| 2015 | -0.57x | $-22.87 Million | $-23.41 Million | $40.37 Million | ▲ +78.8% |
| 2014 | -2.68x | $-69.34 Million | $-69.75 Million | $25.89 Million | ▲ +43.8% |
| 2013 | -4.76x | $-84.84 Million | $-86.06 Million | $17.81 Million | ▼ -22.0% |
| 2012 | -3.91x | $-81.81 Million | $-85.19 Million | $20.95 Million | ▼ -22.0% |
| 2011 | -3.20x | $-67.07 Million | $-69.38 Million | $20.96 Million | ▼ -230.8% |
| 2010 | 2.45x | $50.30 Million | $46.74 Million | $20.56 Million | ▲ +173.6% |
| 2009 | -3.32x | $-102.64 Million | $-102.78 Million | $30.88 Million | ▼ -30.6% |
| 2008 | -2.54x | $-101.01 Million | $-103.52 Million | $39.69 Million | ▼ -66.8% |
| 2007 | -1.53x | $-51.27 Million | $-52.21 Million | $33.61 Million | ▼ -13.6% |
| 2006 | -1.34x | $-34.92 Million | $-35.84 Million | $26.01 Million | ▼ -57.2% |
| 2005 | -0.85x | $-33.38 Million | $-35.17 Million | $39.08 Million | ▲ +38.1% |
| 2004 | -1.38x | $-36.61 Million | $-38.15 Million | $26.52 Million | ▲ +31.2% |
| 2003 | -2.01x | $-31.20 Million | $-32.44 Million | $15.55 Million | ▼ -15.3% |
| 2002 | -1.74x | $-32.89 Million | $-34.53 Million | $18.90 Million | ▼ -138.9% |
| 2001 | -0.73x | $-12.75 Million | $-15.98 Million | $17.51 Million | ▼ -39.4% |
| 2000 | -0.52x | $-7.97 Million | $-11.59 Million | $15.25 Million | ▼ -1051.4% |
| 1999 | -0.05x | $-745.00K | $-7.83 Million | $16.41 Million | — |